Ohio State University, Wexner Medical Center, Columbus, OH, USA
Eur Respir Rev. 2019 Jul 8;28(152). doi: 10.1183/16000617.0003-2019. Print 2019 Jun 30.
Asthma incidence and severity are increased in obese populations. Systematic reviews have shown benefit from weight-loss interventions on asthma outcomes, but the role of bariatric surgery is still unclear. In this review, cohorts of obese asthmatic patients undergoing bariatric surgery were examined regarding different asthma outcomes. The available data on patients who were followed up showed improvements in asthma control, exacerbation risk, asthma-related hospitalisation, medication use and airway hyperresponsiveness, with some patients not requiring further treatment for asthma. Follow-up duration was variable, being mostly of 1 year, with some studies reporting long-term outcomes after 5 years. The studies reviewed had many limitations, including small numbers of patients, lack of control arm in some studies and lack of standardisation of asthma diagnosis, classification and outcome measures, in addition to possible reporting bias. Data on small numbers of patients also show the possibility of benefit exclusively in nonallergic asthma. Larger, more stringent clinical trials are needed before recommending bariatric surgery for treatment of asthma.
肥胖人群的哮喘发病率和严重程度增加。系统评价表明,减肥干预措施对哮喘结局有益,但减重手术的作用仍不清楚。在这篇综述中,研究了接受减重手术的肥胖哮喘患者队列,以观察不同的哮喘结局。对随访患者的现有数据显示,哮喘控制、加重风险、哮喘相关住院、药物使用和气道高反应性得到改善,一些患者不再需要进一步治疗哮喘。随访时间长短不一,大多为 1 年,一些研究报告了 5 年后的长期结果。所审查的研究存在许多局限性,包括患者数量少、一些研究缺乏对照组以及哮喘诊断、分类和结果测量缺乏标准化,此外还可能存在报告偏倚。少数患者的数据也表明,减重手术可能仅对非过敏性哮喘有益。在推荐减重手术治疗哮喘之前,需要进行更大规模、更严格的临床试验。